Acute inflammatory demyelinating polyneuropathy
Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy: a case report
... as acute inflammatory demyelinating polyneuropathy in a 30-year-old man testing positive for Immunodeficiency Virus, probably during acute ...
5
Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy : a case report
... as acute inflammatory demyelinating polyneuropathy in a 30-year-old man testing positive for Immunodeficiency Virus, probably during acute ...
5
Anti ganglioside Antibody profile in GBS - Clinical, Immunological and Neurophysiological significance.
... the demyelinating variant varies by ...Europe, acute inflammatory demyelinating polyneuropathy is the major form, reporetd in up to 90% of Guillain-Barré syndrome ...
90
View of Guillain-Barre, Syndrome: Clinical Profile | Journal of Current Medical Research and Opinion
... of acute inflammatory demyelinating polyneuropathy (AIDP), Axonal involvement in 8 (16%) cases and mixed in 22 (44%) patients Figures 3 and 4 ...
5
Guillain-Barre syndrome observed with adoptive transfer of lymphocytes genetically engineered with an NY-ESO-1 reactive T-cell receptor
... paresthesia, and heaviness to both legs progressing to difficulty walking on the day of presentation. Although MRI brain and lumbar puncture were negative, electromyography (EMG) and nerve conduction studies (NCS) of the ...
7
Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study
... 5]. Acute inflammatory demyelinating polyneuropathy (AIDP) [3, 4] with sensory-motor involvement is the predominant form in the Western world whereas most patients in Asian countries have the ...
9
Pathway construction of chronic inflammatory demyelinating polyneuropathy (CIPD): a neurodegenerative disease
... in Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre syndrome) (Hafer-Macko et ...nerve, inflammatory demyelination starting at the level of the nerve roots (Nicolas and ...
7
Comparison of electrophysiological findings in axonal and demyelinating Guillain-Barre syndrome.
... groups: acute inflammatory demyelinating polyneuropathy (AIDP), acute motor axonal neuropathy (AMAN), and acute motor sensory axonal neuropathy ...
6
Chronic inflammatory demyelinating polyneuropathy-like neuropathy as an initial presentation of Crohn’s disease
... one acute pro- gressive symptom, which was not differentiated from acute inflammatory demyelinating polyradiculoneuropathy (AIDP) ...typical demyelinating-type nerve- conduction ...an ...
5
A study of Peripheral Neuropathy in HIV infected patients.
... symmetrical polyneuropathy (DSP) were 18 (69.2%), distal symmetric polyneuropathy with only sensory findings (Distal Sensory Polyneuropathy) were 2 ...the inflammatory demyelinating ...
110
Sural nerve T-cell receptor V gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy
... A second explanation might be that the total number of T cells in the nerve biopsy specimens affected the number of positive V  genes detected in the PCR analysis, as positivity was highest in the vasculitis group and ...
10
Autonomic Dysfunction in Iraqi Patients with Chronic Inflammatory Demyelinating Polyneuropathy
... chronic inflammatory demyelinating polyradiculoneuropathy [CIDP] has been used to identify patients with a chronically progressive or relapsing symmetric sensorimotor disorder with cytoalbuminologic ...
9
Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy
... Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) disease severity is assessed by Medical Research Counsil (MRC) Scale or Inflammatory Neuropathy Cause and Treatment (INCAT) disability ...
9
An Overview on Guillain Barre Syndrome
... Pathogenesis of C jejuni: The pathogenesis of C jejuni associated Guillain-Barré syndrome is explained on the basis of a mechanism called molecular mimicry. Gangliosides are important surface molecules of the nervous ...
10
Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP)
... A clear limitation of our animal model is that the complex experimental procedures increased the variabil- ity in outcome measures to an extent that prevented us to collect convincing in vivo evidence for this hypoth- ...
9
Acute Facial Dyplegia and Rhabdomyolisis: Case Report and Review of Literature
... The postulated mechanisms of action of IVIg in neuromuscular disorders include interference with costimulatory molecules involved in antigen presentation and modulation of autoantibodies, cyotokines and adhesion ...
8
Suspected Pheochromocytoma in a Patient With Guillain-Barré Syndrome
... plasma and urine catecholamine levels were elevated only in patients with GBS who had autonomic instability. The question of why increased catechol- amine levels are seen in such patients remains incompletely answered. ...
6
Nerve ultrasound characterizes AMN polyneuropathy as inhomogeneous and focal hypertrophic
... Due to the limited number of nerve biopsies and the re- striction to the distal sural nerve of patients with AMN it is difficult to define the histopathological basis of HRUS abnormalities in AMN. In contrast, skin ...
7
Pure sensory chronic inflammatory polyneuropathy: rapid deterioration after steroid treatment
... Immune-mediated sensory polyradiculo-neuropathies have long been recognized as a specific type of CIDP. The majority of patients with only sensory symptoms are likely to develop subclinical motor conduction abnormalities ...
5
Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans
... To date, most insights into the immunobiology of inflammatory demyelinating neuropathies (IDP) have been gained from experimental animal studies. The most frequently employed model for GBS is experimen- tal ...
20